ChristinaSing-YingWuMD
Oncology • Scottsdale, AZGastrointestinal Cancer, Hematologic Oncology
Professor of Medicine
Dr. Wu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
13400 E Shea Blvd
Scottsdale, AZ 85259Phone+1 480-301-8000
Education & Training
MedStar Health/Georgetown University HospitalFellowship, Hematology and Medical Oncology, 2008 - 2011
UMass Chan Medical SchoolResidency, Internal Medicine, 2005 - 2008
Boston Medical CenterPost-Doctoral Fellowship, 2003 - 2005
St Vincent's Medical CenterInternship, Transitional Year, 2002 - 2003
University of Dublin Trinity CollegeClass of 2002
Certifications & Licensure
AZ State Medical License 2021 - 2025
GA State Medical License 2016 - 2022
OH State Medical License 2011 - 2017
DC State Medical License 2008 - 2013- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- 83 citationsProstate cancer incidence in males with Lynch syndromeSigurdis Haraldsdottir, Heather Hampel, Lai Wei, Christina Wu, Wendy L. Frankel
Genetics in Medicine. 2014-01-16 - 10 citationsOutcomes in Patients with Obstructive Jaundice from Metastatic Colorectal Cancer and Implications for ManagementShawnn D. Nichols, Scott Albert, Lawrence A. Shirley, Carl Schmidt, Sherif Abdel-Misih
Journal of Gastrointestinal Surgery. 2014-10-10 - 38 citationsImpact of Sarcopenia, BMI, and Inflammatory Biomarkers on Survival in Advanced Hepatocellular Carcinoma Treated With Anti-PD-1 Antibody.Mehmet Akce, Yuan Liu, Katerina Mary Zakka, Dylan J. Martini, Amber Draper
American Journal of Clinical Oncology. 2021-02-01
Press Mentions
Georgia Man Is Proof of Increasing Cases of Advanced Colorectal CancerMarch 31st, 2023- Intermittent FOLFIRI plus Panitumumab Proves More Effective, Less Toxic Than Continuous Treatment in Metastatic Colorectal CancerJuly 8th, 2022
- New Treatment Strategy Eliminated Colon Cancer Without SurgeryFebruary 27th, 2022
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
